Literature DB >> 31649173

Prime editing promises to be a cut above CRISPR.

Jon Cohen.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31649173     DOI： 10.1126/science.366.6464.406

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  5 in total

Review 1.  CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury.

Authors:  Vera Paschon; Felipe Fernandes Correia; Beatriz Cintra Morena; Victor Allisson da Silva; Gustavo Bispo Dos Santos; Maria Cristina Carlan da Silva; Alexandre Fogaça Cristante; Stephanie Michelle Willerth; Florence Evelyne Perrin; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

Review 2.  Gene-Modified Stem Cells for Spinal Cord Injury: a Promising Better Alternative Therapy.

Authors:  Yirui Feng; Yu Li; Ping-Ping Shen; Bin Wang
Journal:  Stem Cell Rev Rep       Date:  2022-05-19       Impact factor: 5.739

Review 3.  Using Gene Editing Approaches to Fine-Tune the Immune System.

Authors:  Kristina Pavlovic; María Tristán-Manzano; Noelia Maldonado-Pérez; Marina Cortijo-Gutierrez; Sabina Sánchez-Hernández; Pedro Justicia-Lirio; M Dolores Carmona; Concha Herrera; Francisco Martin; Karim Benabdellah
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

Review 4.  GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies.

Authors:  Andrés Felipe Leal; Eliana Benincore-Flórez; Daniela Solano-Galarza; Rafael Guillermo Garzón Jaramillo; Olga Yaneth Echeverri-Peña; Diego A Suarez; Carlos Javier Alméciga-Díaz; Angela Johana Espejo-Mojica
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

5.  He Jiankui´s gene-editing experiment and the non-identity problem.

Authors:  Marcos Alonso; Julian Savulescu
Journal:  Bioethics       Date:  2021-05-05       Impact factor: 1.898
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.